VITALIPID

This brand name is authorized in Austria, Cyprus, Ecuador, Estonia, Spain, Finland, Hong Kong, Lithuania, New Zealand, Poland, Romania, Singapore

Active ingredients

The drug VITALIPID contains a combination of these active pharmaceutical ingredients (APIs):

1 Vitamin A
UNII G2SH0XKK91 - RETINOL

Vitamin A plays an important role in the visual process. It is isomerised to the 11-cis isomer and subsequently bound to the opsin to form the photoreceptor for vision under subdued light. Vitamin A also participates in the formation and maintenance of the integrity of epithelial tissues and mucous membranes.

Read about Vitamin A
2 Vitamin D2
UNII VS041H42XC - ERGOCALCIFEROL

Vitamin D2 (ergocalciferol) is a fat soluble vitamin. In conjunction with parathyroid hormone and calcitonin, it regulates calcium haemostasis. Ergocalciferol metabolites promote active absorption of calcium and phosphorous by the small intestine, increase rate of excretion and resorption of minerals in bone and promote resorption of minerals in bone and promote resorption of phosphate by renal tubules.

Read about Vitamin D2
3 Dl-alpha-tocopherol
UNII 7QWA1RIO01 - .ALPHA.-TOCOPHEROL, DL-

Vitamin E is known to exert an important physiological function as an antioxidant for fats, with a sparing action on vitamin A, carotenoids and on unsaturated fatty acids. Other work has demonstrated that vitamin E is connected with the maintenance of certain factors essential for the normal metabolic cycle.

Read about Vitamin E
4 Vitamin K1
UNII A034SE7857 - PHYTONADIONE

The presence of vitamin K (i.e. vitamin K or substances with vitamin K activity) is essential for the formation within the body of prothrombin, factor VII, factor IX and factor X. Lack of vitamin K leads to an increased tendency to haemorrhage. When an antidote to an anticoagulant is necessary it is essential to use vitamin K1 itself, as vitamin K analogues are much less effective.

Read about Vitamin K1

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
A11CB Vitamin A and D in combination A Alimentary tract and metabolism → A11 Vitamins → A11C Vitamin A and D, incl. combinations of the two
Discover more medicines within A11CB
B05XC Vitamins B Blood and blood forming organs → B05 Blood substitutes and perfusion solutions → B05X I.V. solution additives
Discover more medicines within B05XC

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: EC Agencia Nacional de Regulación, Control y Vigilancia Sanitaria Identifier(s): H6030713, H7621013
Country: EE Ravimiamet Identifier(s): 1000191, 1000281
Country: ES Centro de información online de medicamentos de la AEMPS Identifier(s): 61020, 61021
Country: FI Lääkealan turvallisuus- ja kehittämiskeskus Identifier(s): 191064, 191247
Country: HK Department of Health Drug Office Identifier(s): 36205, 36206
Country: LT Valstybinė vaistų kontrolės tarnyba Identifier(s): 1008243, 1008244
Country: NZ Medicines and Medical Devices Safety Authority Identifier(s): 4859, 4860
Country: PL Rejestru Produktów Leczniczych Identifier(s): 100070925, 100070931, 100076780, 100293660, 100357615, 100368062, 100369386, 100371934, 100424010, 100430915, 100443480, 100447821
Country: RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale Identifier(s): W43695002, W43696002
Country: SG Health Sciences Authority Identifier(s): 05207P, 05208P

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.